Key Insights for Improving Adoption of Dual and Concurrent Testing for Cancer Care

Opinion
Video

An expert discusses how education about the clinical impact of genomic testing, understanding of targeted therapies, turnaround times, and team-based approaches are essential to bridge the gap in routine comprehensive genomic profiling adoption.

Video content above is prompted by the following:

Despite increasing adoption, significant gaps remain in routine comprehensive genomic profiling implementation. Education represents a core element in bridging these gaps, particularly regarding the clinical impact and value of identifying driver events for treatment selection. Clinicians need better understanding of both the testing technologies and the downstream therapeutic options available for patients with specific molecular profiles, creating a comprehensive educational approach that links diagnostic capabilities with treatment opportunities.

Enhanced education about turnaround times and behind-the-scenes testing activities helps clinicians better communicate with patients about result timelines and manage expectations effectively. Understanding the complexity of genomic testing processes enables better patient communication and workflow planning. This knowledge also helps clinical teams optimize their processes to minimize delays and ensure efficient test completion.

Successful implementation requires a multidisciplinary team approach where all health care team members understand the importance of genomic test results. Streamlined workflows and optimized processes are essential for decreasing time to results and ensuring test findings are easily visible and accessible to the entire care team. Strategies focus on providing targeted education within teams about genomic testing value and developing efficient workflows for rapid, comprehensive testing completion.

Recent Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
2 experts in this video
2 experts in this video